Posted by Nuvista Pharma Ltd

Endometriosis affects up to 10% of women of reproductive age, and the main goal of treatment is to relieve symptoms. Progestins have been the mainstay of endometriosis suppression, of which dienogest has become an important option in many parts of the world.   A search of PubMed was conducted for papers published between 2007–2019 o...
Take Home Message: Endometriosis is estimated to affect 10–15% of women of childbearing age and as much as 15–30% of those with primary or secondary infertility. Endometriosis associated pelvic pain (EAPP) is the most common complaint of patients with endometriosis. It occurs when endometrial cells proliferate outside the uterus, for...
Global Journal of Reproductive Medicine: Endometriosis is a common disease in up to 10% of women of reproductive age. It often causes symptoms such as dysmenorrhea, chronic pelvic pain, dyspareunia and dyschezia. It is also associated with ovarian endometrioma which requires surgery for both diagnosis and treatment. However, recurrence r...
Journal of Minimally Invasive Gynecology: Published on December 2020 Endometriosis is a common condition affecting women of reproductive age, often presenting with pelvic pain and infertility. In addition to significantly impacting a woman’s quality of life, the treatment of endometriosis carries a considerable economic burden. TAKE...
The New England Journal of Medicine (NEJM): Endometriosis is defined as the presence of endometrium-like tissue outside the uterus. Figure 1. Endometriosis across the Life Course. Endometriosis is primarily diagnosed through surgical visualization — ideally, laparoscopy. Treatment consists of surgical removal of lesions and hormon...